Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Oncogene|July 25, 2003
Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotypeEisaku Higuchi, Roshantha A S Chandraratna, Waun K Hong, et al.
Topics in Current Chemistry|July 4, 2012
Personalizing lung cancer prevention through a reverse migration strategyKathryn A Gold, Edward S Kim, Ignacio I Wistuba, et al.
Cancer Research|April 17, 2002
The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cellsShi-Yong Sun, Ping Yue, Xueyun Chen, et al.
Cancer|September 5, 2002
BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma riskYong Zhu, Margaret R Spitz, Yun-Ling Zheng, et al.
Cancer Research|September 5, 2002
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancerHongbing Shen, Luo Wang, Margaret R Spitz, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysisHongbing Shen, Margaret R Spitz, Yawei Qiao, et al.
Cancer Biology & Therapy|April 23, 2005
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrationsShi-Yong Sun, Claudia P Schroeder, Ping Yue, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
Dietary folate intake and lung cancer risk in former smokers: a case-control analysisHongbing Shen, Qingyi Wei, Patricia C Pillow, et al.
Cancer|March 29, 2002
Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinomaSerap Hastürk, Bonnie Kemp, Shyla K Kalapurakal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3Anne-Thérèse Vlastos, Loyd A West, E Neely Atkinson, et al.
Pageof 7